UNII ETJ7Z6XBU4

SILICON DIOXIDE

Unique Ingredient Identifier ETJ7Z6XBU4 is listed as a ingredient substance
UniiETJ7Z6XBU4
Preferred Substance NameSILICON DIOXIDE
Rn7631-86-9
Ec231-545-4
NcitC29853
Rxcui9771
Molecular FormulaO2Si
InchikeyVYPSYNLAJGMNEJ-UHFFFAOYSA-N
SmilesO=[Si]=O
Unii TypeINGREDIENT SUBSTANCE
RN7631-86-9
EC231-545-4
NCITC29853
RXCUI9771
MFO2Si
INCHI KEYVYPSYNLAJGMNEJ-UHFFFAOYSA-N
SMILESO=[Si]=O

Alternate Names

Dosage Forms

UNII ETJ7Z6XBU4 SILICON DIOXIDE is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALTABLET1.25 MG
BUCCALTABLET, EXTENDED RELEASE0.46 MG
DENTALGEL19 %
DENTALPASTE NA
ENDOCERVICALGEL8 %
INHALATIONPOWDER NA
NASALGEL4 %
ORALCAPSULE100 MG
ORALCAPSULE (IMMED./COMP. RELEASE)2.5 MG
ORALCAPSULE (IMMED./COMP. RELEASE), HARD GELATIN NA
ORALCAPSULE, COATED PELLETS8.61 MG
ORALCAPSULE, COATED, SOFT GELATIN0.5 MG
ORALCAPSULE, DELAYED ACTION13.69 MG
ORALCAPSULE, DELAYED ACTION, COATED, HARD GELATIN1.28 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, DELAYED RELEASE2.6 MG
ORALCAPSULE, ENTERIC COATED PELLETS9.64 MG
ORALCAPSULE, EXTENDED RELEASE15 MG
ORALCAPSULE, GELATIN COATED9 MG
ORALCAPSULE, HARD GELATIN6 MG
ORALCAPSULE, SOFT GELATIN1.73 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED8.8 MG
ORALCAPSULE, SUSTAINED ACTION106 MG
ORALCAPSULE, SUSTAINED ACTION, HARD GELATIN1.7 MG
ORALDISPERSIBLE TABLET16 MG
ORALDROPS NA
ORALFILM, SOLUBLE0.6 MG
ORALFOR SUSPENSION15 MG/5ML
ORALGRANULE100 MG
ORALGRANULE, ENTERIC COATED3.2 MG
ORALGRANULE, for ORAL SOLUTION1.8 MG/SACHET
ORALGRANULE, FOR RECONSTITUTION16.25 MG
ORALGRANULE, FOR SUSPENSION25 MG
ORALGRANULE, FOR SUSPENSION, EXTENDED RELEASE NA
ORALLIQUID,EXTENDED RELEASE2.03 MG/ML
ORALLOZENGE2 mg
ORALPELLET0.088 MG
ORALPOWDER100 MG/1SCP
ORALPOWDER30 MG/1GM
ORALPOWDER0.02 MG
ORALPOWDER, FOR ORAL SOLUTION0.75 MG
ORALPOWDER, FOR ORAL SUSPENSION102 MG/5ML
ORALPOWDER, FOR ORAL SUSPENSION30 MG/PKT
ORALPOWDER, FOR RECONSTITUTION200 MG/5ML
ORALPOWDER, FOR SOLUTION129 MG/1BOT
ORALPOWDER, FOR SOLUTION14.99 MG/POUCH
ORALPOWDER, FOR SUSPENSION125 MG/5ML
ORALPOWDER, FOR SUSPENSION55 MG
ORALSOLUTION33.6 mg
ORALSUSPENSION138 MG/5ML
ORALSUSPENSION, SUSTAINED ACTION21.6 MG/.00577GM
ORALTABLET138.5 mg
ORALTABLET35 MG
ORALTABLET8.3 mg
ORALTABLET (IMMED./COMP. RELEASE), COATED6 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED138 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE84.8 MG
ORALTABLET, CHEWABLE25 MG
ORALTABLET, COATED24 MG
ORALTABLET, CONTROLLED RELEASE5.2 MG
ORALTABLET, DELAYED ACTION170 MG
ORALTABLET, DELAYED ACTION, COATED85 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED85 MG
ORALTABLET, DELAYED RELEASE7 MG
ORALTABLET, DISPERSIBLE6 MG
ORALTABLET, ENTERIC COATED PARTICLES3 MG
ORALTABLET, EXTENDED RELEASE70 MG
ORALTABLET, FILM COATED33 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE17.5 MG
ORALTABLET, FOR SUSPENSION6.25 MG
ORALTABLET, ORALLY DISINTEGRATING20 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE11.5 MG
ORALTABLET, SUGAR COATED0.8 MG
ORALTABLET, SUSTAINED ACTION48 MG
ORALTABLET, SUSTAINED ACTION, COATED7 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED60 MG
ORALTABLET, SUSTAINED RELEASE, FILM COATED30 MG
RECTALSUPPOSITORY14 MG
SUBLINGUALTABLET10 MG
TOPICALGEL0.25 %W/W
TRANSDERMALFILM, CONTROLLED RELEASE49 MG
TRANSDERMALPATCH9.94 MG
VAGINALCREAM, EMULSION, SUSTAINED RELEASE0.75 %W/W
VAGINALEMULSION, CREAM1.01 %
VAGINALINSERT2.5 MG
VAGINALTABLET8 MG
VAGINALTAMPON NA
ORALCAPSULE7 mg
ORALCAPSULE, EXTENDED RELEASE9.48 mg
ORALPOWDER, FOR SUSPENSION27.66 g
ORALTABLET20 mg
ORALTABLET, DELAYED RELEASE15 mg
ORALTABLET, EXTENDED RELEASE54.6 mg
ORALTABLET, FILM COATED5 mg
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE7.8 mg
ORAL-20TABLET4 mg

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.